Advanced Proteome Therapeutics (CVE:APC)

Advanced Proteome Therapeutics (CVE:APC)

Share Price
$ 0.19
0.04 (26.67 %)
Market Cap
$3.99 m
Proactive Investors - Run By Investors For Investors

Advanced Proteome Therapeutics

Advanced Proteome’s vision is to advance the field of protein-site targeting to deliver more effective and personalized cancer therapies faster, accelerate improvement in survival rates, while creating value for all stakeholders. The company plans to fulfill this vision by boldly creating protein therapeutics that carry multiple entities targeted for specific cancer cells. Such protein...

Market: TSX-V:APC
52-week High/Low: C$0.850 / C$0.080
Sector: Pharmaceuticals
Market Cap: $3.99 m
col 3
col 4
col 5
col 6

Advanced Proteome Therapeutics Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use